Expression of E-cadherin in normal oral mucosa, in oral precancerous lesions and in oral carcinomas

European Journal of Dentistry

Volumn 9, Issue 3, 2015, Pages 364-372

  Sridevi, Ugrappa ^a   Jain, Ajay ^a   Nagalaxmi, Velpula ^b   Kumar, Ugrappa Vijay ^b   Goyal, Stuti ^b  

^a AIMST UNIVERSITY   (Malaysia)

^b SREENIDHI INSTITUTE OF SCIENCE AND TECHNOLOGY   (India)

Author keywords

E cadherin; Immunohistochemistry; Oral carcinoma; Oral precancerous lesions

Indexed keywords

EID: 84940029012     PISSN: 13057456     EISSN: 13057464     Source Type: Journal    
DOI: 10.4103/1305-7456.163238     Document Type: Article

References (27)

1. Das RK, Pal M, Barui A, Paul RR, Chakraborty C, Ray AK, et al. Assessment of malignant potential of oral submucous fibrosis through evaluation of p63, E-cadherin and CD105 expression. J Clin Pathol 2010;63:894-9.
2. Narayan S. Oral cancer in India: An epidemiologic and clinical review. Oral Surg Oral Med Oral Pathol 1990;69:325-30.
3. Greenberg MS, Glick M. Burket's Oral Medicine. 11th ed. Hamilton:BC Decker Inc.; 2008.
4. Jankowski JA, Bruton R, Shepherd N, Sanders SA. Cadherin and catenin biology represents a global mechanism for epithelial cancer mechanism. J Clin Pathol Mol Pathol 1997;50:289-90.
5. Wijnhoven BP, Dinjens WN, Pignatelli M. E-cadherin-catenin cell-cell adhesion complex and human cancer. Br J Surg 2000;87:992-1005.
6. Lipponen P, Saarelainen E, Ji H, Aaltomaa S, Syrjänen K. Expression of E-cadherin (E-CD) as related to other prognostic factors and survival in breast cancer. J Pathol 1994;174:101-9.
7. Rajendran R. Oral leukoplakia. J Oral Maxillofac Pathol 2004;8:58-68.
8. van der Waal I. Potentially malignant disorders of the oral and oro-pharyngeal mucosa; terminology, classification and present concepts of management. Oral Oncol 2009;45:317-23.
9. Kiran Kumar K, Saraswathi TR, Ranganathan K, Uma Devi M, Elizabeth J. Oral submucous fibrosis: A clinico-histopathological study in Chennai. Indian J Dent Res 2007;18:106-11.
10. Andreasen JO. Oral lichen planus.1. A clinical evaluation of 115 cases. Oral Surg Oral Med Oral Pathol 1968;25:31-42.
11. Neppelberg E, Loro LL, Oijordsbakken G, Johannessen AC. Altered CD40 and E-cadherin expression - Putative role in oral lichen planus. J Oral Pathol Med 2007;36:153-60.
12. Robbins SL, Kumar V, Cotran RS. Basic Pathology. 7th ed. Philadelphia,U.S: Elsevier Publications; 2003 p. 165-211.
13. Simionescu C, Margaritescu C, Surpateanu M, Mogoanta L, Zavoi R, Ciurea R, et al. The study of E-cadherine and CD44 immunoexpression in oral squamous cell carcinoma. Rom J Morphol Embryol 2008;49:189-93.
14. Gibbons MD, Manne U, Carroll WR, Peters GE, Weiss HL, Grizzle WE. Molecular differences in mucoepidermoid carcinoma and adenoid cystic carcinoma of the major salivary glands. Laryngoscope 2001;111:1373-8.
15. Downer CS, Speight PM. E-cadherin expression in normal, hyperplastic and malignant oral epithelium. Eur J Cancer B Oral Oncol 1993;29B: 303-5.
16. Yogesh T, Narayan T, Shreedhar B, Shashidara R, Leekymohanty. The expression of E-cadherin and cathepsin-D in normal oral mucosa, oral epithelial dysplasia and oral squamous cell carcinoma: A comparative analysis between immunohistochemistry and routine histopathology. J Oral Maxillofac Pathol 2011;15:288-94.
17. Rajendran R, Shivapathasundaram B, editors. Shafer's Textbook of Oral Pathology. 5th ed. New Delhi, India: Reed Elsevier India; 2006.
18. Raina C, Raizada RM, Chaturvedi VN, Harinath BC, Puttewar MP, Kennedy AK. Clinical profile and serum beta-carotene levels in oral submucous fibrosis. Indian J Otolaryngol Head Neck Surg 2005;57:191-5.
19. Yuwanati MB, Tupkari JV, Avadhani A. Expression of E-cadherin in oral epithelial dysplasia and oral squamous cell carcinoma: An in vivo study. J Clin Exp Invest 2011;2:347-53.
20. Chaw SY, Majeed AA, Dalley AJ, Chan A, Stein S, Farah CS. Epithelial to mesenchymal transition (EMT) biomarkers - E-cadherin, beta-catenin, APC and Vimentin - In oral squamous cell carcinogenesis and transformation. Oral Oncol 2012;48:997-1006.
21. Kaur J, Sawhney M, DattaGupta S, Shukla NK, Srivastava A, Walfish PG, et al. Clinical significance of altered expression of ß-catenin and E-cadherin in oral dysplasia and cancer: Potential link with ALCAM expression. PLoS One 2013;8:e67361.
22. Ganapathy KS, Gurudath S, Balikai B, Ballal S, Sujatha D. Role of iron deficiency in oral submucous fibrosis: An initiating or accelerating factor. J Indian Acad Oral Med Radiol2011;23:25-8.
23. Neppelberg E, Johannessen AC. DNA content and Cyclooxygenase-2 as risk markers of cancer development in oral lichen planus. Eur Arch Otorhinolaryngol 2007;264:1223-30.
24. Ebrahimi M, Boldrup L, Wahlin YB, Coates PJ, Nylander K. Decreased expression of the p63 related proteins beta-catenin, E-cadherin and EGFR in oral lichen planus. Oral Oncol 2008;44:634-8.
25. Shinohara M, Hiraki A, Ikebe T, Nakamura S, Kurahara S, Shirasuna K, et al. Immunohistochemical study of desmosomes in oral squamous cell carcinoma: Correlation with cytokeratin and E-cadherin staining, and with tumour behaviour. J Pathol 1998;184:369-81.
26. Diniz-Freitas M, García-Caballero T, Antúnez-López J, Gándara-Rey JM, García-García A. Reduced E-cadherin expression is an indicator of unfavourable prognosis in oral squamous cell carcinoma. Oral Oncol 2006;42:190-200.
27. Hung KF, Chang CS, Liu CJ, Lui MT, Cheng CY, Kao SY. Differential expression of E-cadherin in metastatic lesions comparing to primary oral squamous cell carcinoma. J Oral Pathol Med 2006;35:589-94.